8 Jan, Morning Brief

Gap up opening expected as SGX Nifty is trading up by 42 points.

Breakout closing on the charts for the last session will lead another spurt in the indices inching towards a target of 11200. Stock specific movements can be witnessed as Q3 results session has been kicked off.

🎯 News & Impact 🎯

🎯 Goa Carbon :
Revenue at Rs.186.6 crore Vs RS 82 crore
Net profit at Rs.22.50 crore Vs net loss of Rs.0.93 cr.
Positive for the stock.

🎯 Sobha :
Sales volume up 8.3%, sales value up 3% QoQ.
Sales volume up 52% and sale vales up 63.5% YoY.
Positive for the stock.

🎯 NBCC :
Company secured work from Ecotourism Development Corporation of Uttarakhand, Dehradun amounting Rs.2000 crore.
Positive for the stock.

🎯 Sagar Cements :
Company's sales up 65 % (YoY) at 2,54,348 million tonnes versus 1,54,195 million tonnes.
Positive for the stock.

🎯 Sun Pharma :
The US Food and Drug Administration is expected to begin inspection of Sun Pharma's manufacturing facility at Halol in the second week of February.
Cautious over the stock.

🎯 Infy :
CLSA has a 'buy' rating on Infosys with a target price of Rs.1,230.

🎯 Tata Steel :
1.2% drop in saleable steel production in the country to 3.24 million tonnes YoY.
Sales of 3.3 million tonnes in Q3 FY18.

🎯 Brigade Enterprises :
Bengaluru-based Brigade Enterprises Ltd, which is in the process of moving all its hotel assets into a separate unit, may consider listing the new entity as a real estate investment trust (REIT) or going public in the future.

🎯 Jaypee Infratech :
Tata Housing and the Lodha Group have filed initial bids for Jaypee Infratech.

🎯 JPAssociates :
The Jaypee Group has restructured its outstanding foreign currency convertible bonds (FCCBs).

🎯 Telecom stocks :
Reliance Jio Infocomm (Jio) unleashed another price disruption in an heavily debt-riddled industry, wherein all existing tariff plans with 1GB data have been revised to offer either 50 per cent more data or a Rs 50 discount, a move which could hit the average revenue per user of rivals such as Bharti Airtel, Vodafone India and Idea Cellular.

🎯 Buy back :
SJVN & Aarti Drugs

Edited by Sharp.
© Sharp Investment & Financial Advisers